Charts FibroBiologics, Inc.

Stocks

Market Closed - Nasdaq 00:00:00 31/10/2026 +04			5-day change	1st Jan Change
0.9300 ^USD	+0.20%		-2.11%	-79.32%

10-14	Fibrobiologics, Inc. Announces Australian Patent Accepted for Cellular Blend for the Regeneration of Chondrocytes and Cartilage Cells in Degenerated Spinal Discs	CI
10-08	FibroBiologics, Inc. announced that it has received $1.02 million in funding from Peak One Investments, LLC	CI

NasdaqUSD

Markets		Quality
Nasdaq	FBLG	Delayed
CBOE	FBLG	Real-time

ProRealTime Chart